William B. Walkup & Associates’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.9K Sell
1,754
-405
-19% -$6.28K 0.01% 117
2026
Q1
$18.8K Buy
2,159
+3
+0.1% +$42 0.01% 118
2025
Q4
$26.8K Hold
2,156
0.01% 113
2025
Q3
$21.3K Sell
2,156
-3
-0.1% -$29 0.01% 119
2025
Q2
$19.3K Hold
2,159
0.01% 118
2025
Q1
$18.8K Buy
2,159
+161
+8% +$1.69K 0.01% 117
2024
Q4
$24.9K Hold
1,998
0.02% 112
2024
Q3
$23.2K Sell
1,998
-61
-3% -$704 0.01% 114
2024
Q2
$21.9K Buy
+2,059
New +$22.8K 0.01% 116

Other funds holding VTRS

William B. Walkup & Associates's VTRS Position: Q2 2026 in Review

William B. Walkup & Associates reduced its Viatris (VTRS) stake by 19% in Q2 2026, selling an estimated $6.28K and leaving 1,754 shares worth $27.9K. The position accounts for 0.01% of the portfolio, ranked #117.

William B. Walkup & Associates first reported a position in VTRS in Q2 2024 and has held it in 9 quarters since. 411 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • William B. Walkup & Associates held 1,754 shares of Viatris worth $27.9K as of Q2 2026.
  • William B. Walkup & Associates sold 405 Viatris shares in Q2 2026, an estimated $6.28K.
  • Viatris made up 0.01% of William B. Walkup & Associates's portfolio in Q2 2026, its #117 holding.
  • William B. Walkup & Associates first reported a position in Viatris in Q2 2024 and has held it in 9 quarters since.
  • 411 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on William B. Walkup & Associates's 13F filing for Q2 2026, filed 30 Jul 2026.